Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.40 -0.05 (-11.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Cost of Revenue (2022)

Updated

Pasithea Therapeutics (KTTA) reported Cost of Revenue of -$1,308 for Q4 2022.

Analysis

Pasithea Therapeutics (KTTA) Cost of Revenue (2022) Analysis & Trends

For FY2022, Pasithea Therapeutics posted Cost of Revenue of $113,195, up 555.3% from FY2021.

  • By year, Cost of Revenue came in at $17,275 in FY2021.
  • Per Business Quant data, the three quarters before Q4 2022 came in at $86,465 (Q3 2022), $15,101 (Q2 2022) and $12,937 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Pasithea Therapeutics 13.37 Mn -142.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1,308.00
Sep 30, 2022 86,465.00
Jun 30, 2022 15,101.00
Mar 31, 2022 12,937.00
API Access

Pasithea Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KTTA&period=max&api_key=YOUR_API_KEY